Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

The 2025-26 Merck Analyte Quarterly Update is Here!

Beyond Biomarkers! 

Expect reliable measurements, a simplified user experience, and knowledgeable scientific partners to help drive your biomarker projects. Abacus dx is committed to delivering the best possible immunoassays from Merck for your research needs.

Whether you are using Merck’s industry-leading MILLIPLEX® multiplex panels to broadly survey multiple analytes, performing femtogram/mL biomarker analysis using the FemtoQuest™ ultrasensitive immunoassay platform, or examining single proteins with our tried-and-true ELISAs and RIAs, you can confidently expect reliable measurements, a simplified user experience, and knowledgeable scientific partners to help drive your biomarker project from hypothesis to publication.

2025-26 Merck Analyte Quarterly Update

Download Here >


2025-26 Merck Analyte Quarterly Update

Download Here >

Request a Quote

Request Quote

Recent Posts

Healing Eyes with Precision: Research Empowered by Merck’s MILLIPLEX® Technology

Imagine using part of your blood to help heal your eyes A study by Liu et al. (2025) explores a new way to treat corneal neovascularization, a condition…

Read full article

PeptiGrowth – Why use Synthesised Peptide Alternatives to Growth Factors

Advance Your Organoid Research with PeptiGrowth’s PG004 & PG008 Are you striving for consistency, reproducibility, and xeno-free conditions in your organoid cultures? PeptiGrowth is proud to…

Read full article

TriLink – CleanCap® M6 IVT Kit, High Yield

Streamline your mRNA synthesis with TriLink’s CleanCap® IVT kits, which yield up to 1 mg per 100 µL reaction. Designed for efficiency and excellence, these kits include all…

Read full article